Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thibaut Reverdy

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Cancers|August 29, 2020
Front-Line Maintenance Therapy in Advanced Ovarian Cancer-Current Advances and PerspectivesThibaut Reverdy, Christophe Sajous, Julien Péron, et al.
Breast Cancer Research and Treatment|January 27, 2026
Second-line treatment strategy following CDK4/6 inhibitors for HR-positive and HER2-negative metastatic breast cancer patients: a multicentric, retrospective, observational studyOlivia Lavigne, François Poumeaud, Thibaut Reverdy, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 7, 2025
Prognostic Value of a Joint K-PD Model With Tumor Size Dynamics and CA-125 Kinetics in Recurrent Ovarian Cancer Patients: BOLD Phase II GINECO StudyAurore Carrot, Pauline Corbaux, Olivier Colomban, et al.
Clinical Genitourinary Cancer|December 5, 2025
Impact of FGFR3 Alterations on First-Line Platinum Based Chemotherapy in Patients With Metastatic or Locally Advanced Urothelial Carcinoma: The Retrospective IFUCA StudyThibaut Reverdy, Floriane Izarn, Benoit Allignet, et al.
Cancers|June 2, 2021
Investigating the Impact of Immune-Related Adverse Events, Glucocorticoid Use and Immunotherapy Interruption on Long-Term Survival OutcomesCharline Lafayolle de la Bruyère, Pierre-Jean Souquet, Stéphane Dalle, et al.
The Oncologist|September 14, 2024
Early follow-up of outpatients with oral anticancer therapy in the ONCORAL multidisciplinary community-hospital programClaire Lattard, Chloé Herledan, Thibaut Reverdy, et al.
Head & Neck|May 1, 2026
Systemic Treatments for Recurrent or Metastatic Sinonasal Carcinomas: A Retrospective Multicenter StudyMarie Degrange, Mathilde Morisseau, Justin Michel, et al.
Gynecologic Oncology|October 13, 2019
Clinical factors associated with prolonged response and survival under olaparib as maintenance therapy in BRCA mutated ovarian cancersS Intidhar Labidi-Galy, Thibault de La Motte Rouge, Olfa Derbel, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Cancers|August 29, 2020
Front-Line Maintenance Therapy in Advanced Ovarian Cancer-Current Advances and PerspectivesThibaut Reverdy, Christophe Sajous, Julien Péron, et al.
Breast Cancer Research and Treatment|January 27, 2026
Second-line treatment strategy following CDK4/6 inhibitors for HR-positive and HER2-negative metastatic breast cancer patients: a multicentric, retrospective, observational studyOlivia Lavigne, François Poumeaud, Thibaut Reverdy, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 7, 2025
Prognostic Value of a Joint K-PD Model With Tumor Size Dynamics and CA-125 Kinetics in Recurrent Ovarian Cancer Patients: BOLD Phase II GINECO StudyAurore Carrot, Pauline Corbaux, Olivier Colomban, et al.
Clinical Genitourinary Cancer|December 5, 2025
Impact of FGFR3 Alterations on First-Line Platinum Based Chemotherapy in Patients With Metastatic or Locally Advanced Urothelial Carcinoma: The Retrospective IFUCA StudyThibaut Reverdy, Floriane Izarn, Benoit Allignet, et al.
Cancers|June 2, 2021
Investigating the Impact of Immune-Related Adverse Events, Glucocorticoid Use and Immunotherapy Interruption on Long-Term Survival OutcomesCharline Lafayolle de la Bruyère, Pierre-Jean Souquet, Stéphane Dalle, et al.
The Oncologist|September 14, 2024
Early follow-up of outpatients with oral anticancer therapy in the ONCORAL multidisciplinary community-hospital programClaire Lattard, Chloé Herledan, Thibaut Reverdy, et al.
Head & Neck|May 1, 2026
Systemic Treatments for Recurrent or Metastatic Sinonasal Carcinomas: A Retrospective Multicenter StudyMarie Degrange, Mathilde Morisseau, Justin Michel, et al.
Gynecologic Oncology|October 13, 2019
Clinical factors associated with prolonged response and survival under olaparib as maintenance therapy in BRCA mutated ovarian cancersS Intidhar Labidi-Galy, Thibault de La Motte Rouge, Olfa Derbel, et al.
Pageof 2